Fresenius Kabi Joins NHIA Future of Infusion Advisory Council

LAKE ZURICH, Ill., April 28, 2026 – The National Home Infusion Association (NHIA) and Fresenius Kabi announced today that Fresenius Kabi has joined NHIA's Future of Infusion Advisory Council (FIAC). The FIAC is a strategic advisory group comprising manufacturing and service companies that support home and alternate site infusion professionals. The group works with the association staff and board of directors to address critical issues, challenges, and opportunities facing this growing segment of patient care.

For Fresenius Kabi, membership in the FIAC provides the opportunity to support the advancement of infusion care delivery in America.

“Fresenius Kabi is committed to supporting patients who rely on infusion therapies, and joining NHIA’s Future of Infusion Advisory Council provides an important forum to advance this work,” said Pete Allen, Senior Vice President, IV Therapy and Nutrition, Fresenius Kabi USA. “We are focused on delivering high-quality parenteral nutrition and IV solutions and enhancing U.S. supply reliability through continued investment in manufacturing. We look forward to further advancing infusion care across the country.” 

Fresenius Kabi, a part of Fresenius, is a leading provider of essential medicines and medical technologies for infusion, transfusion, and clinical nutrition. In the U.S., the company offers a broad portfolio of essential, high-quality medicines and operates an expanding network of state-of-the-art manufacturing facilities. Across North America, Fresenius Kabi is committed to enhancing supply reliability and supporting clinicians and patients who depend on its products. 

"We're pleased to welcome Fresenius Kabi to FIAC," said Connie Sullivan, NHIA President and CEO. "As a leading manufacturer serving the infusion community, Fresenius Kabi brings critical perspectives that will help advance our shared mission to ensure patients receive the highest quality infusion care."

About NHIA 

National Home Infusion Association (NHIA) is a trade association that represents companies accredited to provide medically necessary infusion therapies to patients with acute and chronic health conditions, as well as companies that manufacture and supply infusion related products and services. Infusion therapy involves patient-specific compounded medications, supplies, and a range of pharmacy, nursing, and other clinical services for delivering care to patients in the home or suite setting.

About Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving essential medicines and technologies.

In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of  parenteral nutrition products designed to support patient’s nutritional needs. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.

Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.

For more information, please visit www.fresenius-kabi.com/us. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn and Facebook.

###